Open AccessRole of lapatinib alone or in combination in the treatment of HER2-positive breast cancer
Author(s) -
Sara A. Hurvitz,
Reva Kakkar
Publication year - 2012
Publication title -
breast cancer
Language(s) - English
Resource type - Journals
ISSN - 1179-1314
DOI - 10.2147/bctt.s29996
Subject(s) - lapatinib , medicine , trastuzumab , breast cancer , oncology , metastatic breast cancer , cancer , clinical trial
This review aims to present the preclinical and clinical data regarding efficacy and safety of lapatinib alone and in combination with other agents in the treatment of human epidermal growth factor receptor-2 (HER2)-overexpressing breast cancer.